Clinical Trial

Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding

Study acronym: ADENOTREAT
Recruiting
View on ClinicalTrials.gov →
Summary
The present study aims to compare the efficacy (menstrual blood loss, pain, quality of life) and the safety (complications, recovery) of each conservative intervention (RFA, UAE) versus hysterectomy for the treatment of adenomyosis-related abnormal uterine bleeding, up to 2 years
Protocol Amendment History 2 changes
critical Recruitment opened 2026-04-21
notable Trial sites expanded: 1 -> 4 locations 2026-04-21
Trial Details
NCT Number NCT07195305
Lead Sponsor University Hospital, Bordeaux
Collaborators: Ministry of Health, France
Conditions Abnormal Uterine Bleeding Due to Adenomyosis (Disorder)
Enrollment 230 participants
Start Date 2026-04-17
Primary Completion 2029-05 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-20